The first severe COVID-19 patient successfully treated with human recombinant soluble ACE2 (hrsACE2) with disappearance of coronavirus swiftly from the serum nasal cavity and lungs and a reduction of inflammatory cytokine levels leading to a significant clinical improvement.
Upvoted: The first severe COVID-19 patient successfully treated with human recombinant soluble ACE2 (hrsACE2), with disappearance of coronavirus swiftly from the serum, nasal cavity and lungs, and a reduction of inflammatory cytokine levels, leading to a significant clinical improvement. via /r/science https://ift.tt/3l5n8eL